{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:18:20Z","timestamp":1790882300618,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50 CA196530"],"award-info":[{"award-number":["P50 CA196530"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA206483"],"award-info":[{"award-number":["R01CA206483"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007433"],"award-info":[{"award-number":["T32AI007433"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.cllc.2020.11.006","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T20:13:29Z","timestamp":1606853609000},"page":"e498-e505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Decreased Overall Survival in HIV-associated Non\u2013small-cell Lung Cancer"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-3817","authenticated-orcid":false,"given":"Kristen","family":"Hysell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-9283","authenticated-orcid":false,"given":"Michael","family":"Virata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-754X","authenticated-orcid":false,"given":"Geliang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Perez-Irizarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresita","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brinda","family":"Emu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2020.11.006_bib1","doi-asserted-by":"crossref","first-page":"dju503","DOI":"10.1093\/jnci\/dju503","article-title":"Excess cancers among HIV-infected people in the United States","volume":"107","author":"Robbins","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2020.11.006_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2020.11.006_bib3","doi-asserted-by":"crossref","first-page":"e0129550","DOI":"10.1371\/journal.pone.0129550","article-title":"Cancer-related causes of death among HIV-infected patients in France in 2010: evolution since 2000","volume":"10","author":"Vandenhende","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2020.11.006_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2020.11.006_bib5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0000000000000222","article-title":"Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000","volume":"28","author":"Morlat","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.cllc.2020.11.006_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/CCO.0b013e328355e131","article-title":"HIV infection, aging, and immune function: implications for cancer risk and prevention","volume":"24","author":"Dubrow","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.cllc.2020.11.006_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2020.11.006_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/QAD.0b013e328329216a","article-title":"Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities","volume":"23","author":"Engels","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.cllc.2020.11.006_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1513\/pats.201009-058WR","article-title":"Cigarette smoking in the HIV-infected population","volume":"8","author":"Rahmanian","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.cllc.2020.11.006_bib10","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.cllc.2020.11.006_bib11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1158\/1055-9965.EPI-16-0964","article-title":"Excess mortality among HIV-infected individuals with cancer in the United States","volume":"26","author":"Coghill","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cllc.2020.11.006_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/COH.0000000000000326","article-title":"Lung cancer in persons with HIV","volume":"12","author":"Sigel","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.cllc.2020.11.006_bib13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/thx.2005.052373","article-title":"Lung cancer\u00a0in HIV infected patients: facts, questions and challenges","volume":"61","author":"Cadranel","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.cllc.2020.11.006_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/596766","article-title":"Changes in cancer mortality among HIV-infected patients: the Mortalite 2005 survey","volume":"48","author":"Bonnet","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cllc.2020.11.006_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1378\/chest.12-1699","article-title":"Epidemic of lung cancer in patients with HIV infection","volume":"143","author":"Winstone","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2020.11.006_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/QAI.0b013e31817dc42b","article-title":"Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters","volume":"48","author":"Shiels","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cllc.2020.11.006_bib17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/QAD.0b013e328352d1ad","article-title":"HIV as an independent risk factor for incident lung cancer","volume":"26","author":"Sigel","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.cllc.2020.11.006_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/518606","article-title":"HIV infection is associated with an increased risk for lung cancer, independent of smoking","volume":"45","author":"Kirk","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cllc.2020.11.006_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/QAI.0b013e3181f53783","article-title":"Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users","volume":"55","author":"Shiels","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cllc.2020.11.006_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAI.0b013e3181eef4f7","article-title":"Pulmonary infections and risk of lung cancer among persons with AIDS","volume":"55","author":"Shebl","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cllc.2020.11.006_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-153-7-201010050-00008","article-title":"Age at cancer diagnosis among persons with AIDS in the United States","volume":"153","author":"Shiels","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cllc.2020.11.006_bib22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S2213-2600(14)70017-7","article-title":"HIV-associated obstructive lung diseases: insights and implications for the clinician","volume":"2","author":"Drummond","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cllc.2020.11.006_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non\u2013small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cllc.2020.11.006_bib24","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/bjc.2013.545","article-title":"Prognosis in HIV-infected patients with non-small cell lung cancer","volume":"109","author":"Sigel","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2020.11.006_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.qai.0000164033.02947.e3","article-title":"Survival after cancer diagnosis in persons with AIDS","volume":"39","author":"Biggar","year":"2005","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cllc.2020.11.006_bib26","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1055-9965.EPI-14-1079","article-title":"Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers","volume":"24","author":"Marcus","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cllc.2020.11.006_bib27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D","article-title":"Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors","volume":"88","author":"Tirelli","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2020.11.006_bib28","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/ijc.29603","article-title":"Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort","volume":"137","author":"Hleyhel","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2020.11.006_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.bjc.6601111","article-title":"Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?","volume":"89","author":"Powles","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2020.11.006_bib30","first-page":"1","article-title":"Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged\u00a0<18 months and\u00a0for HIV infection and AIDS among children aged 18 months to\u00a0<13 years--United States, 2008","volume":"57","author":"Schneider","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cllc.2020.11.006_bib31","series-title":"American Joint Committee on Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.cllc.2020.11.006_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAD.0b013e32835ad56e","article-title":"Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals","volume":"27","author":"Suneja","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.cllc.2020.11.006_bib33","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States","volume":"32","author":"Suneja","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2020.11.006_bib34","doi-asserted-by":"crossref","first-page":"1902066","DOI":"10.1183\/13993003.02066-2019","article-title":"First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial","volume":"56","author":"Lavole","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cllc.2020.11.006_bib35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamaoncol.2018.6737","article-title":"Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: a systematic review","volume":"5","author":"Cook","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2020.11.006_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/1753465817750075","article-title":"Role of immune-checkpoint inhibitors in lung cancer","volume":"12","author":"Jain","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.cllc.2020.11.006_bib37","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamaoncol.2019.2244","article-title":"Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer-a phase 1 study","volume":"5","author":"Uldrick","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2020.11.006_bib38","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1097\/QAD.0000000000002298","article-title":"Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience","volume":"33","author":"Spano","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.cllc.2020.11.006_bib39","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/bjc.2017.333","article-title":"Clinically significant mutations in HIV-infected patients with lung adenocarcinoma","volume":"117","author":"Thaler","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2020.11.006_bib40","doi-asserted-by":"crossref","first-page":"e0361","DOI":"10.1097\/MD.0000000000010361","article-title":"Human immunodeficiency virus infection and mortality risk among lung cancer patients: a systematic review and meta-analysis","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cllc.2020.11.006_bib41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/QAD.0000000000000690","article-title":"Lung cancer incidence and survival among HIV-infected and uninfected women and men","volume":"29","author":"Hessol","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.cllc.2020.11.006_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/CLEP.S10193","article-title":"Hepatitis C virus infection and risk of cancer: a population-based cohort study","volume":"2","author":"Omland","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.cllc.2020.11.006_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/M16-0240","article-title":"Chronic hepatitis B and C virus infection and risk for non-Hodgkin lymphoma in HIV-infected patients: a cohort study","volume":"166","author":"Wang","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cllc.2020.11.006_bib44","doi-asserted-by":"crossref","first-page":"djw035","DOI":"10.1093\/jnci\/djw035","article-title":"Association between hepatitis C virus and head and neck cancers","volume":"108","author":"Mahale","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2020.11.006_bib45","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2015.04.021","article-title":"Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010","volume":"63","author":"Allison","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cllc.2020.11.006_bib46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00002030-200003310-00011","article-title":"Cancer risk among men with, or at risk of, HIV infection in southern Europe","volume":"14","author":"Serraino","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.cllc.2020.11.006_bib47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.athoracsur.2011.11.012","article-title":"Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer","volume":"93","author":"Hooker","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2020.11.006_bib48","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199509283331305","article-title":"Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group","volume":"333","author":"Hirschtick","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2020.11.006_bib49","first-page":"OF1","volume":"10","year":"2020","journal-title":"Cancer Disc"},{"key":"10.1016\/j.cllc.2020.11.006_bib50","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730420303399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730420303399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:12:55Z","timestamp":1761505975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730420303399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1525730420303399"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2020.11.006","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased Overall Survival in HIV-associated Non\u2013small-cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2020.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}